These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37884615)

  • 1. Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study.
    Kaplan S; Kaufman RP; Mueller T; Elterman D; Chughtai B; Rukstalis D; Woo H; Roehrborn C
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):485-491. PubMed ID: 37884615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore.
    Chay J; Tung JYM; Su RJ; Aslim EJ; Wong C; Swan G; Chua WJ; Ho HSS; Finkelstein EA
    J Med Econ; 2023; 26(1):1269-1277. PubMed ID: 37800562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Fu S; Bhattacharyya SK; El-Arabi AM; Cutone BJ; McVary KT
    PLoS One; 2022; 17(4):e0266824. PubMed ID: 35427376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and management of BPH surgery-related urethral stricture: results from a large U.S. database.
    Licari LC; Bologna E; Manfredi C; Franco A; Ditonno F; De Nunzio C; Antonelli A; Simone G; De Sio M; Cindolo L; Olweny EO; Cherullo EE; Leonardo C; Autorino R
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):537-543. PubMed ID: 38714780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Private Payer and Patient Out-of-Pocket Costs Associated With the Surgical Management of Benign Prostatic Hyperplasia.
    Wymer KM; Thao V; Narang G; Sharma V; Borah BJ; Cheney S; Humphreys MR
    Urology; 2024 Feb; 184():87-93. PubMed ID: 38065310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
    Raizenne BL; Zheng X; Oumedjbeur K; Mao J; Zorn KC; Elterman D; Bhojani N; McClure T; Te A; Kaplan S; Sedrakyan A; Chughtai B
    World J Urol; 2023 Jan; 41(1):179-188. PubMed ID: 36463348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum)
    Chin CP; Garden EB; Ravivarapu KT; Shukla D; Omidele O; Levy M; Qian D; Araya JS; Valenzuela R; Reddy A; Marshall S; Motola J; Nobert C; Gupta M; Small AC; Kaplan SA; Palese MA
    J Endourol; 2022 Dec; 36(12):1559-1566. PubMed ID: 36039926
    [No Abstract]   [Full Text] [Related]  

  • 11. Benign Prostatic Hyperplasia Endoscopic Surgical Procedures in Kidney Transplant Recipients: A Comparison Between Holmium Laser Enucleation of the Prostate, GreenLight Photoselective Vaporization of the Prostate, and Transurethral Resection of the Prostate.
    Prudhomme T; Marquette T; Péré M; Patard PM; Michiels C; Sallusto F; Rigaud J; Glémain P; Kamar N; Blancho G; Soulié M; Rischmann P; Karam G; Gamé X; Robert G; Branchereau J
    J Endourol; 2020 Feb; 34(2):184-191. PubMed ID: 31588793
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta-analysis.
    Franco JVA; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    BJU Int; 2022 Aug; 130(2):142-156. PubMed ID: 34820997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Amorosi SL; Shore ND
    J Health Econ Outcomes Res; 2021 May; 8(1):42-50. PubMed ID: 33987450
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study.
    Sahakyan Y; Erman A; Bhojani N; Chughtai B; Zorn KC; Sander B; Elterman DS
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):113-118. PubMed ID: 35689083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary Trends of Holmium Laser Enucleation of the Prostate Utilization in the United States: A Comprehensive Analysis Using the National Surgical Quality Improvement Program Database (2011-2020).
    Abdelaziz A; Bhandari M; Elshabrawy A; Trecarten S; Dalla EE; Samara KA; Alsayegh F; Liss M; Mansour AM
    J Endourol; 2024 May; 38(5):521-528. PubMed ID: 38299559
    [No Abstract]   [Full Text] [Related]  

  • 16. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Hwang EC; Jung JH; Borofsky M; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013143. PubMed ID: 30759311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign Prostatic Hyperplasia Surgery: A Snapshot of Trends, Costs, and Surgical Retreatment Rates in the USA.
    Ditonno F; Manfredi C; Licari LC; Bologna E; Franco A; Pandolfo SD; De Sio M; De Nunzio C; Fiori C; Cherullo EE; Olweny EO; Antonelli A; Autorino R
    Eur Urol Focus; 2024 Apr; ():. PubMed ID: 38670842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimally Invasive Treatments for Benign Prostatic Obstruction: A Systematic Review and Network Meta-analysis.
    Cornu JN; Zantek P; Burtt G; Martin C; Martin A; Springate C; Chughtai B
    Eur Urol; 2023 Jun; 83(6):534-547. PubMed ID: 36964042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Surgical Reintervention for Benign Prostatic Hyperplasia Following Prostatic Urethral Lift, Transurethral Resection of the Prostate, and Photoselective Vaporization of the Prostate: A TriNetX Analysis.
    Feiertag JH; Kane JA; Clark JY
    Eur Urol Open Sci; 2024 Jan; 59():63-70. PubMed ID: 38298771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.